EN DE
STOCK COMPARISON

Embecta vs Intuitive Surgical: Fair Value & Quality

Both stocks run through our valuation models. Here is how Embecta (EMBC) and Intuitive Surgical (ISRG) compare, as of Aug 29, 2026.

As of Aug 29, 2026, Fair Value Calculator sees Embecta as the less overvalued of the two: Embecta trades at $5.05 versus a fair value of $3.15 (-38%), while Intuitive Surgical trades at $373 versus $150 (-60%).
Embecta
EMBC · USD · Health Care
-38%
upside to fair value
overvalued
Price$5.05
Fair Value$3.15
Quality73/100
Intuitive Surgical
ISRG · USD · Health Care
-60%
upside to fair value
overvalued
Price$373
Fair Value$150
Quality72/100
Get comparisons like this free by email every month: the most undervalued quality stocks.

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

EmbectaIntuitive Surgical
Valuation
2.7×P/E (TTM)48.3×
0.18×P/S (TTM)13.35×
P/B7.92×
4.1×EV/EBITDA35.5×
PEG2.13×
11.9%Dividend yield
$0.60Dividend per share
Profitability
11%Net margin28%
19%Operating margin31%
Return on equity17%
17%Return on assets10%
Growth
-14%Revenue growth (YoY)23%
-1.5%Avg. growth/yr (3Y)17.4%
-0.1%Avg. growth/yr (5Y)18.2%
Balance & size
$185MMarket cap$141B
weakGrowth qualityhealthy

Intuitive Surgical leads: 4 to 5 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Embectaof which business quality 70 · market factors 29 Intuitive Surgicalof which business quality 71 · market factors 19
ProfitabilityMargins and returns on capital today
69
66
Quality GrowthAre margins and returns improving?
62
66
CashflowEarnings quality: real cash, not paper profit
85
79
Fin. StrengthBalance sheet, leverage, solvency risk
44
82
InvestmentDisciplined investing over empire-building
100
37
Low VolatilityCalm price path (market factor)
38
38
MomentumPrice trend over the last 3–12 months (market factor)
33
15
52W MomentumDistance to the 52-week high (market factor)
9
5
Net IssuanceBuybacks instead of dilution
71
80

What the models say

The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.

Embecta

DCF Models$14.24
Earnings-Based$16.32
Dividend Discount$4.58
Multiples$35.38
Growth DCF$16.36
Economic Profit$19.95
Growth Earnings$26.72

2 of 20 models see the stock below the current price.

Intuitive Surgical

DCF Models$219
Earnings-Based$160
Dividend Discount$0.40
Multiples$144
Asset-Based$33.72
Growth DCF$185
Economic Profit$105
Growth Earnings$224

25 of 26 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

Embecta
Bear $2.39Fair Value $3.15Bull $3.82
$5.05 = current price (white tick)
Intuitive Surgical
Bear $108Fair Value $150Bull $225
$373 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Embecta · Health Care

Quality score73 · Top 25%
Fair value upside-38% · below median

Intuitive Surgical · Health Care

Quality score72 · Top 25%
Fair value upside-60% · below median

Bottom line

As of Aug 29, 2026, Fair Value Calculator sees Embecta as the less overvalued of the two: Embecta trades at $5.05 versus a fair value of $3.15 (-38%), while Intuitive Surgical trades at $373 versus $150 (-60%).

Embecta has the higher quality score (73/100).

See the full analysis →

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 26 models. Values change with price and fundamentals; the date shown above applies.